Administering Geriatric Pneumonia Cases without Waiting for CRP Results, is It Practicable?

Yıl 2022, Cilt: 12 Sayı: 2, 211 - 216, 15.03.2022

Ahmet Cizmecioglu , Mevlüt Hakan Göktepe , Hilal Akay Çizmecioglu , Ahmet Emre Hatır , Handan Bardakçı

https://doi.org/10.16899/jcm.955434

Cited By: 1

Öz

Background: C-reactive protein (CRP) is a notable marker of many diseases. Accordingly, in most cases, the clinical management of infectious diseases is revised based on CRP alterations. This study thus attempted to predict CRP alterations via immature granulocyte count (IGC) and nucleated red blood cell count (NRBC) in a geriatric population with pneumonia.
Methods: We carried out our study in the intensive care unit of a private hospital by retrospectively reviewing the laboratory findings of geriatric patients with pneumonia and an age-matched control group in the same ICU.
Results: In total, we reviewed 495 hospitalization days (the summed amount of days for all 43 patients) and 221 hospitalization days (the summed amount of days for all 20 controls) records. In the group comparisons, we found a statistical significance in the patient group for both IGC (p = 0.001) and NRBC (p = 0.002). Comparing IGC to CRP measures from the following day and the day after that, there was a statistical significance in IGC (p = 0.001) but not in NRBC (p = 0.156). Further, IGCs below 0.3 x 103 and above 0.5 x 103 were better able to predict CRP alterations.
Conclusion: In geriatric patients with pneumonia, IGC is more effective than NRBC in predicting CRP variations before their actual occurrence, with the mean estimation time at least 2 days prior.

Anahtar Kelimeler

CRP variability, Geriatric pneumonia, Immature granulocyte count, Intensive care unit, Nucleated red blood cell count.

Kaynakça

• 1. Quinton LJ, Walkey AJ, Mizgerd JP. Integrative Physiology of Pneumonia. Physiol Rev. 2018 Jul 1;98(3):1417-1464.
• 2. Aspinall R, Lang PO. Interventions to restore appropriate immune function in the elderly. Immun Ageing. 2018;15:5.
• 3. Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, Yale SH. Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine. WMJ. 2016 Dec;115(6):317-21.
• 4. Pepys MB, Hirschfield GM. C-reactive protein: a critical update [published correction appears in J Clin Invest. 2003 Jul;112(2):299].
• 5. Green Y, Petignat PA, Perrier A. [Proper usage of procalcitonin]. Rev Med Suisse. 2007;3(129):2330-2, 4.
• 6. Sbrana A, Torchio M, Comolli G, Antonuzzo A, Danova M; Italian Network for Supportive Care in Oncology (NICSO). Use of procalcitonin in clinical oncology: a literature review. New Microbiol. 2016 Jul;39(3):174-180.
• 7. Lipinski M, Rydzewska G. Immature granulocytes predict severe acute pancreatitis independently of systemic inflammatory response syndrome. Prz Gastroenterol. 2017;12(2):140-4.
• 8. Ekici-Günay N, Çakır I, Çelik T. Is there clinical value in counting nucleated red blood cells and platelet indices in primary immunodeficiency disease? Turk J Pediatr. 2017;59(6):657-663.
• 9. Purtle SW, Horkan CM, Moromizato T, Gibbons FK, Christopher KB. Nucleated red blood cells, critical illness survivors and postdischarge outcomes: a cohort study. Crit Care. 2017 Jun 21;21(1):154.
• 10. Buoro S, Manenti B, Seghezzi M, Dominoni P, Barbui T, Ghirardi A, et al. Innovative haematological parameters for early diagnosis of sepsis in adult patients admitted in intensive care unit. J Clin Pathol. 2018;71(4):330-5.
• 11. Ekici-Gunay N, Cakir I, Celik T. Is there clinical value in counting nucleated red blood cells and platelet indices in primary immunodeficiency disease? Turk J Pediatr. 2017;59(6):657-63.
• 12. Bogaty P, Dagenais GR, Joseph L, Boyer L, Leblanc A, Bélisle P, Brophy JM. Time variability of C-reactive protein: implications for clinical risk stratification. PLoS One. 2013 Apr 8;8(4):e60759.
• 13. Baig U, Laxm V, Ojha A, Watve M. Geriatric infections: Decreased immunity or evolved opportunists? J Biosci. 2020;45(1):57.
• 14. Finnegan R. Coding notes ... ICD-10. J Am Med Rec Assoc. 1990;61(10):26.
• 15. Price T, Miller L, deScossa M. The Glasgow Coma Scale in intensive care: a study. Nurs Crit Care. 2000;5(4):170-3.
• 16. M Bruegel GF, G Matthes, J Thiery. Reference Values for Immature Granulocytes in Healthy Blood Donors generated on the Sysmex XE-2100 Automated Hematology Analyser. Sysmex Journal International. 2004;14(1).
• 17. Pavare J, Grope I, Gardovska D. Assessment of Immature Granulocytes Percentage to Predict Severe Bacterial Infection in Latvian Children: An Analysis of Secondary Data. Medicina (Kaunas). 2018;54(4).
• 18. Park JS, Kim JS, Kim YJ, Kim WY. Utility of the immature granulocyte percentage for diagnosing acute appendicitis among clinically suspected appendicitis in adult. J Clin Lab Anal. 2018;32(7):e22458.
• 19. Ballantine JD, Kwon S, Liem RI. Nucleated Red Blood Cells in Children With Sickle Cell Disease Hospitalized for Pain. J Pediatr Hematol Oncol. 2019.